125 related articles for article (PubMed ID: 27003776)
1. Histopathological assessment of residual retroperitoneal mass removed in patients after chemotherapy for non-seminomatous germ cell tumours of the testis.
Jaszczyński J; Wilk W; Kruczak A; Wohadlo Ł; Faron P; Łuczyńska E; Chłosta P; Stelmach A; Jakubowicz J
Pol J Pathol; 2015 Dec; 66(4):420-5. PubMed ID: 27003776
[TBL] [Abstract][Full Text] [Related]
2. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
3. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
[TBL] [Abstract][Full Text] [Related]
4. Residual retroperitoneal tumour tissue in patients treated for metastatic non-seminomatous testicular germ cell tumours: an immunohistochemical investigation.
Jacobsen GK; Olsen J
Tumour Biol; 1985; 6(1):25-35. PubMed ID: 2410971
[TBL] [Abstract][Full Text] [Related]
5. Redefining the refined retroperitoneal lymph node dissection in testis cancer: a SWOT analysis of nonrandomized data.
Garnick MB
J Clin Oncol; 2007 Oct; 25(28):4337-8. PubMed ID: 17906195
[No Abstract] [Full Text] [Related]
6. Clinical impact of MDR1-expression in testicular germ cell cancer.
Schrader AJ; Seger M; Konrad L; Olbert P; Hegele A; Hofmann R; Heidenreich A
Exp Oncol; 2007 Sep; 29(3):212-6. PubMed ID: 18004247
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.
Mano R; Becerra MF; Carver BS; Bosl GJ; Motzer RJ; Bajorin DF; Feldman DR; Sheinfeld J
J Urol; 2017 Feb; 197(2):391-397. PubMed ID: 27720783
[TBL] [Abstract][Full Text] [Related]
8. Testicular tumors: residual retroperitoneal mass surgery after chemotherapy;Is it possible to predict their histology?
Medina-Polo J; Martínez-Silva V; Domínguez-Esteban M; de la Rosa-Kehrmann F; Villacampa-Aubá F; Castellano-Gauna D; Díaz-González R
Arch Esp Urol; 2011 Sep; 64(7):611-9. PubMed ID: 21965259
[TBL] [Abstract][Full Text] [Related]
9. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
[TBL] [Abstract][Full Text] [Related]
10. Results of treatment of non-seminomatous tumours of the testis in pathological stage I.
Wobbes T; Schraffordt Koops H; Oldhoff J; Sleijfer DT; Oosterhuis JW
Neth J Surg; 1983 Jul; 35(3):89-93. PubMed ID: 6310445
[No Abstract] [Full Text] [Related]
11. Non-seminomatous testicular metastasis mimicking acute appendicitis.
Beddy P; Neary P; Crotty P; Keane FB
Surgeon; 2006 Jun; 4(3):175-7. PubMed ID: 16764204
[TBL] [Abstract][Full Text] [Related]
12. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
13. Extragonadal retroperitoneal germ cell tumors without apparent testicular involvement. A search for the source.
Saltzman B; Pitts WR; Vaughan ED
Urology; 1986 Jun; 27(6):504-7. PubMed ID: 3012846
[TBL] [Abstract][Full Text] [Related]
14. Testicular germ cell tumor seven years after a retroperitoneal germ cell tumor.
González Quintela A; López Bonet E; Román J; Aramburo P
Eur Urol; 1991; 19(4):336-8. PubMed ID: 1655464
[TBL] [Abstract][Full Text] [Related]
15. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
[TBL] [Abstract][Full Text] [Related]
16. The ultimate effect of intraoperative radiotherapy (IORT) on an irresectable retroperitoneal recurrence of a non-seminomatous testicular tumour.
Cromheecke M; Mehta DM; Sleijfer DT; Molenaar WM; Schraffordt Koops H; Hoekstra HJ
Radiother Oncol; 1993 Dec; 29(3):352-4. PubMed ID: 8127988
[No Abstract] [Full Text] [Related]
17. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours.
Hartmann JT; Candelaria M; Kuczyk MA; Schmoll HJ; Bokemeyer C
Eur J Cancer; 1997 May; 33(6):843-7. PubMed ID: 9291803
[TBL] [Abstract][Full Text] [Related]
18. [Surgical management of retroperitoneal metastases from germ cell cancers].
Houlgatte A
Prog Urol; 2008 Nov; 18 Suppl 7():S382-7. PubMed ID: 19070819
[TBL] [Abstract][Full Text] [Related]
19. Modified retroperitoneal lymph node dissection for post-chemotherapy residual tumour: a long-term update.
Cho JS; Kaimakliotis HZ; Cary C; Masterson TA; Beck S; Foster R
BJU Int; 2017 Jul; 120(1):104-108. PubMed ID: 28296054
[TBL] [Abstract][Full Text] [Related]
20. Radical retroperitoneal node dissection after chemotherapy for testicular tumours.
Williams SN; Jenkins BJ; Baithun SI; Oliver RT; Blandy JP
Br J Urol; 1989 Jun; 63(6):641-3. PubMed ID: 2546643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
